<p>HMEC-1 cells were seeded to a density of 1,500 cells/well. After 24 h of incubation, a zero point control was stained with crystal violet. The remaining cells were left untreated as positive control or treated with 0.3-1-3-10–30 µM of the indicated compounds. After 72 h additional incubation, relative proliferation was determined by crystal violet staining and quantified as absorption at 550 nm.</p
<p>Human umbilical cord vein endothelial cells (HUVEC), human lung microvascular endothelial cells (...
<p>Cells were cultured in medium with 2.5% FCS containing HA HMW-HA or MMW-HA or LMW-HA at 0.2%. Pro...
<p>HepG2 cells (2.5×10<sup>4</sup>/mL) were incubated for 4 h to allow sufficient attachment. For th...
<p>αMEM containing 10% FBS was included in the study as a positive control. 72 h later, the media we...
Proliferation of HMEC-1 cells measured by WST-1 proliferation assays. HMEC-1 cells which had been tr...
<p>Growth inhibition assay performed on HUVEC and EPC after 72-h incubation of a conventional regime...
<p>(A) Cell growth curve was evaluated using trypan blue staining to measure viable cells at 24, 48 ...
<p>The endothelial EA.hy926 cells were incubated with VCC251801 and reference compounds in 0.4–50 μM...
<p>(A) HUVECs transfected with RNAiMax only, 10nM dsCON, or 10nM of Flt a-1 (N = 6) were fixed and s...
<p>Human dermal microendothelial cells (HDEC), human umbilical vein endothelial cells (HUVEC), human...
<p>HUVECs (1×10<sup>4</sup>/well) were incubated in ECM (5% FBS, 1% ECGS) with different concentrati...
<p>A) The dose response used to determine the optimal concentration IP-10p (10 µM) used to compare t...
<p>A: HMEC-1 cells were seeded in the same density as for the proliferation assay and treated with t...
<p>MDA cell (2.5×10<sup>4</sup>/mL) were incubated for 6 h to allow sufficient attachment. For the l...
<p><sup>a</sup>Test samples were dissolved in DMSO and then added to cell culture. Final concentrati...
<p>Human umbilical cord vein endothelial cells (HUVEC), human lung microvascular endothelial cells (...
<p>Cells were cultured in medium with 2.5% FCS containing HA HMW-HA or MMW-HA or LMW-HA at 0.2%. Pro...
<p>HepG2 cells (2.5×10<sup>4</sup>/mL) were incubated for 4 h to allow sufficient attachment. For th...
<p>αMEM containing 10% FBS was included in the study as a positive control. 72 h later, the media we...
Proliferation of HMEC-1 cells measured by WST-1 proliferation assays. HMEC-1 cells which had been tr...
<p>Growth inhibition assay performed on HUVEC and EPC after 72-h incubation of a conventional regime...
<p>(A) Cell growth curve was evaluated using trypan blue staining to measure viable cells at 24, 48 ...
<p>The endothelial EA.hy926 cells were incubated with VCC251801 and reference compounds in 0.4–50 μM...
<p>(A) HUVECs transfected with RNAiMax only, 10nM dsCON, or 10nM of Flt a-1 (N = 6) were fixed and s...
<p>Human dermal microendothelial cells (HDEC), human umbilical vein endothelial cells (HUVEC), human...
<p>HUVECs (1×10<sup>4</sup>/well) were incubated in ECM (5% FBS, 1% ECGS) with different concentrati...
<p>A) The dose response used to determine the optimal concentration IP-10p (10 µM) used to compare t...
<p>A: HMEC-1 cells were seeded in the same density as for the proliferation assay and treated with t...
<p>MDA cell (2.5×10<sup>4</sup>/mL) were incubated for 6 h to allow sufficient attachment. For the l...
<p><sup>a</sup>Test samples were dissolved in DMSO and then added to cell culture. Final concentrati...
<p>Human umbilical cord vein endothelial cells (HUVEC), human lung microvascular endothelial cells (...
<p>Cells were cultured in medium with 2.5% FCS containing HA HMW-HA or MMW-HA or LMW-HA at 0.2%. Pro...
<p>HepG2 cells (2.5×10<sup>4</sup>/mL) were incubated for 4 h to allow sufficient attachment. For th...